Long-term disability outcomes in relapsing-remitting multiple sclerosis: A 10-year follow-up study

被引：0
|
作者：
Drulovic, Jelena [1 ,2 ]
Pekmezovic, Tatjana [2 ]
Mesaros, Sarlota [1 ,2 ]
Dujmovic, Irena [1 ,2 ]
Martinovic, Vanja [2 ]
Ivanovic, Jovana [1 ]
Hellwig, Kerstin [3 ]
机构：
[1] Clin Ctr Serbia, Clin Neurol, Belgrade, Serbia
[2] Univ Belgrade, Fac Med, Belgrade, Serbia
[3] St Josef Hosp Bochum, Bochum, Germany
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2.399
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Avonex® 15-year long-term follow-up study of patients with relapsing multiple sclerosis
    Bermel, Robert A.
    Weinstock-Guttman, Bianca
    Bourdette, Dennis N.
    Rudick, Richard A.
    Zhang, Hao
    Foulds, Pamela
    MULTIPLE SCLEROSIS, 2008, 14 : S32 - S32
  • [32] Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression
    Barcutean, Laura
    Maier, Smaranda
    Bajko, Zoltan
    Stoian, Adina
    Mosora, Oana
    Sarmasan, Emanuela
    Manescu, Ion-Bogdan
    Balasa, Rodica
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
  • [33] Relapsing-remitting multiple sclerosis: a long-term observation of immunomodulatory therapy
    Romanowski, F
    Straube, E
    Heinemann, J
    Rhein, R
    JOURNAL OF NEUROLOGY, 2004, 251 : 152 - 152
  • [34] Long-term adherence to interferon β therapy in relapsing-remitting multiple sclerosis
    Portaccio, E.
    Zipoli, V.
    Siracusa, G.
    Sorbi, S.
    Amato, M. P.
    EUROPEAN NEUROLOGY, 2008, 59 (3-4) : 131 - 135
  • [35] Leukocyte dynamics following alemtuzumab treatment of relapsing-remitting multiple sclerosis: long-term follow-up of CAMMS223 patients
    Selmaj, K.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S181 - S181
  • [36] PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Somilo, O., V
    Kalbus, O., I
    Makarov, S. O.
    Sorokin, A. V.
    Shastun, N. P.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 147 - 152
  • [37] Disability trajectories in relapsing-remitting multiple sclerosis
    Uher, T.
    Horakova, D.
    Havrdova, E. Kubala
    Izquierdo, G.
    Eichau, S.
    Patti, F.
    Prat, A. P.
    Girard, M.
    Duquette, P.
    Grammond, P.
    Onofrj, M.
    Lugaresi, A. L.
    Bergamaschi, R.
    Ozakbas, S.
    Grand'Maison, F.
    Hupperts, R.
    Sola, P.
    Ferraro, D.
    Sa, M. J.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 813 - 814
  • [38] A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis
    Pietrzak, Anna
    Kalinowska-Lyszczarz, Alicja
    Osztynowicz, Krystyna
    Khamidulla, Alima
    Kozubski, Wojciech
    Michalak, Slawomir
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (07): : 841 - 851
  • [39] The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis
    Derfuss, T.
    Sastre-Garriga, J.
    Montalban, X.
    Rodegher, M.
    Wuerfel, J.
    Gaetano, L.
    Tomic, D.
    Azmon, A.
    Wolf, C.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (01)
  • [40] A 10-Year Follow-Up Study on Long-Term Clinical Outcomes of Lumbar Microendoscopic Discectomy
    Wang, M.
    Zhou, Y.
    Wang, J.
    Zhang, Z.
    Li, C.
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2012, 73 (04) : 195 - 198
12345